Introduction
Epilepsy is a neurological disorder that affects the quality of life of millions of people around the world. It is characterised by frequent and chronic seizures, which occur due to sudden bursts of electrical impulses in the brain. The most common form of epilepsy in adults is the Mesial Temporal Lobe Epilepsy (MTLE).1
The electrical impulses that trigger MTLE originate from various structures within the temporal lobe, and are usually attributed to hippocampal sclerosis (a condition where the hippocampus undergoes cell loss and scarring).2 MTLE is important not only due to its high prevalence, but also because it is usually resistant to medication and treatment. Many individuals who suffer from MTLE experience significant effects on memory and cognition, which can impact their quality of life.3 In order for patients to receive appropriate treatment from caregivers and healthcare professionals, it is important to understand MTLE, its symptoms, causes, diagnosis, and treatment options.
Understanding MTLE
Anatomy and Definition
MTLE originated from the mesial (inner) structures of the temporal lobe, which are formed of:
- The Hippocampus – an essential part of the brain for the formation of memory and spatial navigation
- The Amygdala – which plays an important role in various emotions such as fear and anxiety
- The Parahippocampal Gyrus – a crucial part of memory retrieval and encoding
These structures of the inner temporal lobe are vital for cognition and the regulation of emotions. When they are affected by the electrical surges of epilepsy, it can lead to a range of symptoms that impact the daily life of the individual.
Symptoms
Individuals who suffer from MTLE usually experience a distinct series of seizure-related symptoms, which could include:
- Auras: These act as ‘warning signs’ that a seizure is about to happen. Common auras include sudden fear, déjà vu (a sense of familiarity), jamais vu (a feeling of unfamiliarity with known surroundings), or a rising sensation in the stomach
- Focal seizures with impaired awareness: In this form of seizure, the individual may look awake but is completely unresponsive to surrounding stimuli. They may also exhibit repetitions in movements such as chewing, lip-smacking, or hand-wringing
- Disturbances in cognition: Short-term memory lapses and confusion are also indicators of an epileptic episode
- Secondary generalisation: In severe cases, the electrical impulses of seizures spread to both hemispheres of the brain, resulting in full convulsive seizures (also known as tonic-clonic seizures)
Causes and Risk Factors of MTLE
The seizures that persist in MTLE can be caused by various factors, which can include:
- Hippocampal Sclerosis (HS): This is the most common cause of MTLE, which involves the loss of neurons and visible scarring of the hippocampus following years of seizures that begin in childhood4
- Trauma to the head: Any injury to the brain can cause damage, particularly those affecting the temporal lobe, which can trigger MTLE later in life5
- Brain Infections: Infections such as meningitis and encephalitis can cause inflammation and scarring of the brain tissue, increasing the risk of epilepsy6
- Genetic: There is some suggestion that there could be a genetic predisposition in some families to an individual’s risk of developing MTLE7
- Perinatal Injury: A lack of oxygen or trauma during birth can cause damage to the brain, which may contribute to the development of epilepsy later in life8
Diagnosis
In order to determine the best treatment approach, MTLE must be accurately diagnosed using the following diagnostic process:
- Clinical Evaluation and Medical History: A detailed medical history would be taken by a neurologist. This includes the history of the onset of seizure episodes, any known triggers, and family history
- Electroencephalogram (EEG): Brain activity is recorded using an EEG machine to detect abnormal electrical patterns that are characteristic of epilepsy
- Magnetic Resonance Imaging (MRI): The MRI machine is used to create high-resolution images of the brain in order to identify the presence of any structural abnormalities
- Video-EEG Monitoring: Some patients may benefit from prolonged monitoring in an epilepsy-specific centre to capture and determine the point of origin of the seizures
- Neuropsychological Testing: Patients are assessed on the quality of their memory, language, and cognitive function, which can help identify the affected area of the brain
Treatment Options
The management of MTLE requires each patient to be seen individually, depending on the severity of their seizures. A personalised approach can lead to better outcomes of treatment.
Medications
Medications known as anti-epileptic drugs (AEDs) are available that are the first-line treatment. The most commonly prescribed medications include:
- Carbamazepine
- Lamotrigine
- Levetiracetam
- Oxcarbazepine
- Sodium Valproate
It is important to note that approximately 30-40% of patients cannot control their seizures with medications alone, making them candidates for alternative treatment methods.9
Surgical Options
When MTLE is resistant to medication, patients are given the option of surgical procedures. These may include:
- Anterior Temporal Lobectomy (ATL): This is the most common type of surgery for MTLE, in which part of the temporal lobe is removed
- Selective Amygdalohippocampectomy (SAH): This surgery involves removing two structures of the brain (the amygdala and hippocampus) while preserving surrounding tissues10
Studies have shown that approximately 60-80% of individuals suffering from MTLE who undergo some form of surgery will achieve long-term seizure freedom.11
Neurostimulation Therapies
Patients who are not eligible for surgery may be offered neurostimulation therapy. This can include various techniques such as:
- Vagus Nerve Stimulation (VNS): A device is implanted into the brain, sending electrical impulses to the vagus nerve to reduce the frequency of seizures12
- Responsive Neurostimulation (RNS): A device detects electrical activity in the brain and delivers targeted electrical stimulation to prevent seizures13
- Deep Brain Stimulation (DBS): Electrodes are implanted deep into the brain to regulate abnormal electrical activities14
Dietary Therapies
There are some suggestions that dietary modifications, such as the ketogenic diet (a high-fat, low-carb diet), can help reduce the frequency of seizures. In fact, studies have shown that in individuals who fail to respond to medications, adherence to a strict ketogenic diet can significantly reduce the frequency of seizures. This makes it a very appropriate non-surgical option. A more flexible and tolerable diet is the modified Atkins diet, which is easier to follow and still maintains the high-fat, low-carb principle. New evidence has emerged showing that other dietary alternatives, such as the low glycaemic index treatment (LGIT), which works by stabilising blood sugar levels, may also help in reducing the severity of seizures.15
Conclusion
Although Mesial Temporal Lobe Epilepsy is complex and affects individuals significantly, the symptoms are very well characterised. Even though individuals may find that their condition is resistant to medications, there are other options available, such as surgical techniques and neurostimulation, which can provide effective treatment. However, management of MTLE does not only involve treatment, but it also often requires a holistic approach that involves modifications in diet, psychological support, as well as lifestyle adjustments. Research into the treatment of epilepsy is ongoing and aims to expand the scope for seizure control and therefore improve quality of life. Therefore, it is important to understand the impact of MTLE in order to help individuals take a more proactive approach in seeking appropriate treatment and thereby managing their condition more effectively.16
References
- Engel J. Mesial temporal lobe epilepsy: what have we learned? Neuroscientist. 2001 Aug;7(4):340–52.
- Blümcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: A Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia [Internet]. 2013 Jul [cited 2025 Mar 14];54(7):1315–29. Available from: https://onlinelibrary.wiley.com/doi/10.1111/epi.12220
- Helmstaedter C, Kockelmann E. Cognitive outcomes in patients with chronic temporal lobe epilepsy. Epilepsia. 2006;47 Suppl 2:96–8.
- Thom M. Hippocampal sclerosis: progress since Sommer. Brain Pathol. 2009 Oct;19(4):565–72.
- Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998 Jan 1;338(1):20–4.
- Singh A, Trevick S. The epidemiology of global epilepsy. Neurologic Clinics [Internet]. 2016 Nov 1 [cited 2025 Mar 14];34(4):837–47. Available from: https://www.sciencedirect.com/science/article/pii/S0733861916300378
- Vadlamudi L, Andermann E, Lombroso CT, Schachter SC, Milne RL, Hopper JL, et al. Epilepsy in twins: insights from unique historical data of William Lennox. Neurology. 2004 Apr 13;62(7):1127–33.
- Cowan LD. The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev [Internet]. 2002 Jan [cited 2025 Mar 14];8(3):171–81. Available from: https://onlinelibrary.wiley.com/doi/10.1002/mrdd.10035
- Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000 Feb 3;342(5):314–9.
- Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med [Internet]. 2001 Aug 2 [cited 2025 Mar 14];345(5):311–8. Available from: http://www.nejm.org/doi/abs/10.1056/NEJM200108023450501
- Téllez-Zenteno JF, Dhar R, Wiebe S. Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain. 2005 May;128(Pt 5):1188–98.
- Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response; a review. In: Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] [Internet]. Centre for Reviews and Dissemination (UK); 2011 [cited 2025 Mar 14]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK85232/
- Morrell MJ. In response: The RNS System multicenter randomized double-blinded controlled trial of responsive cortical stimulation for adjunctive treatment of intractable partial epilepsy: knowledge and insights gained. Epilepsia. 2014 Sep;55(9):1470–1.
- Fisher R, Salanova V, Witt T, Worth R, Henry T, Gross R, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010 May;51(5):899–908.
- Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008 Jun;7(6):500–6.
- Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015 Jan 20;313(3):285–93.

